Nyrada Inc |
High $0.03 |
Low $0.03 |
Trades 20 |
Turnover $17,485 |
Volume 622,600 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $133,825,608 (1,377th) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 622,600 |
Shortsold (6-Nov) 27,920 (0.01%) (580th) |
|
52w High $1.44 |
52w Low $0.390 |
P/E - |
EPS -0.03 |
Annual Report to 30 June 2021
NYR released this announcement to the ASX on 30 August 2021, 16:53. The announcement is not marked as price sensitive, and is 65 page(s) in length and 3.52MB in size.
You can view all announcements from NYR and see how they appear on a price chart on the announcements page.
At the date of this announcement, NYR was 0.001% short sold according to ASIC data. It was ranked the 633rd most shorted stock on the ASX. It is now ranked as the 580th most shorted stock on the ASX with 0.011% of total shares short sold as of the latest reported data (06 November 2026).
| Other Recent Announcements from NYR | |
|---|---|
| Cholesterol-Lowering Program Update | 26 June 2023, 9:55 |
| Brain Injury Program Preclinical Development Update | 9 June 2023, 8:18 |
| Cholesterol-Lowering Program Preclinical Studies Completed | 26 May 2023, 8:44 |
| Annual Report to 30 June 2021 | 30 August 2021, 16:53 |
| Preliminary Final Report | 30 August 2021, 16:44 |
| Appendix 4G and Corporate Governance Statement | 30 August 2021, 16:40 |
| NYX-PCSK9i In Vivo Study Exploratory Analysis Results | 13 August 2021, 9:00 |
If you were already registered, log in here.